Table 3.

Kaposi sarcoma incidence rates in patients on ART in resource-rich and resource-limited regions.

Authors	Cohort	Country	Calendar years	Patients on ART	KS incidence rate per 100, 000 pys
Resource-rich regions				N	Children	Adults
Ledergerber 199931	SHCS	Switzerland	1995 – 1999	2,410	NR	140
Clifford 200514	SHCS	Switzerland	1985 – 2003	NR	NR	109
Franceschi 200811	SHCS	Switzerland	1984 – 2006	NR	NR	130
Suárez-García 201313	CoRIS/ CoRIS-MD	Spain	1997 – 2008	NR	NR	199
Carrieri 200332	DMI-2	France	1996 – 2001	2,589	NR	122
Lacombe 201316	FHDH-ANRS CO4	France, French overseas territories	1992 – 2009	40,083	NR	137
Mocroft 200033	EuroSIDA	Europe, Israel	1994 – 1999	NR	NR	700
Lodi 201029 *	CASCADE	Europe, Australia, Canada	1986 – 2006	4,199	NR	358
Yanik 201315	CNICS	USA	1996 – 2011	11,485	NR	304
Resource-limited regions
Fink 201112	CCASAnet/ IeDEA	Caribbean, Central and South America	2007 – 2009	3,372	NR	450
Asiimwe 20129	HBAC	Uganda	2003 – 2008	1,121	NR	340
Martin 20128	IeDEA	Uganda	2008 – 2011	NR	NR	201
Martin 20128	IeDEA	Kenya	2008 – 2011	NR	NR	270
Current study	IeDEA	Southern Africa	2004 – 2010	173,245	59	173

Adapted from Semeere et al 2012.⁴ CASCADE, Concerted Action of Seroconversion to AIDS and Death in Europe; CCASAnet, Caribbean, Central and South American network for HIV Research; CNICS, Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems; CoRIS/CoRIS-MD, Spanish cohorts of naïve HIV-infected patients; DMI-2, longitudinal database of HIV-infected individuals followed at Nice University Hospital, France; EuroSIDA, Collection of European cohort studies; FHDH-ANRS CO4, The French Hospital Database on HIV; HBAC, Home-Based AIDS Care programme; IeDEA, International epidemiological Databases to Evaluate AIDS; SHCS, Swiss HIV Cohort Study. Estimates from different studies are adjusted for different variables. ART, antiretroviral therapy; NR, not reported; pys, person-years.

^*Includes only men who have sex with men.